期刊文献+

转人B7.2基因的L929细胞对T细胞增殖和分泌IL-10的作用 被引量:1

Effect of the human B7.2 transfectant on the improvement of T cell proliferation and secretion of IL-10
下载PDF
导出
摘要 应用RT-PCR法,从由LPS刺激的人的DC细胞中抽提mRNA,扩增获得编码人B7.2分子的cDNA,并将其克隆到PMD18-T载体,经PCR、酶切及测序进行鉴定确证,进而构建PEGZ-term-B7.2的真核表达载体。脂质体法共转染包装细胞293T,用含有完整病毒颗粒的293T细胞的上清感染L929细胞,经Zeocin筛选,建立稳定表达人B7.2分子的L929基因转染细胞株。并证实了B7.2基因转染细胞能有效地促进T细胞的体外增殖和促进IL-10的分泌。 The cDNA fragment encoding the hunman B7.2 was obtained from the mRNA of LPS-activated dendritic cells(DC) by using RT-PCR and cloned into the PMD18-T vector. By DNA sequencing, the cDNA was consistent with the reported human B7.2 cDNA in the GenBank, and then was inserted into the eukaryotic expression vector PEGZ-term. The recombinant plasmid was transfected into 293T cell line with Lipofectamine. The culture supernatant of 293T cell line including the complete virus particles was used to transfect L929 cell line. Selected by Zeocin after transfection, a stable cell line expressing the human B7.2 was established. It can increase the proliferation of T cells and the secretion of IL-10 efficiently.
出处 《现代免疫学》 CAS CSCD 北大核心 2005年第3期200-203,共4页 Current Immunology
基金 国家973资助项目(2001CB510003)国家自然科学基金重点资助项目(30330540)
关键词 人的B7.2 基因转染 T细胞 human B7.2 gene transfection T cell
  • 相关文献

参考文献10

  • 1Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation[J]. Annu Rev Immunol, 1996,14:233-258.
  • 2Freeman GJ,Gribben JG,Boussiotis VA, et al. Cloning of B7.2:CTLA-4 counter-receptor that costimulate human T cell proliferation[J]. Science, 1993,262:909-911.
  • 3Lewis L, Shawn O, Chamorro S, et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL[J]. J lmmunol,1995,154:97-105.
  • 4Beatriz M, Mary C. The B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune responses[J]. Annu Rev Immunol, 2002,20:29-53.
  • 5Boussiotis VA, Freeman GJ, Gribben JG, et al. Activated human B lymphocytes express three CTLA-4 counter receptors that costimulate T-cell activation[J]. Proc Natl Acad Sci USA, 1993,90:11059-11063.
  • 6Azuma M, Ito D, Yagita H, et al. B7-0 antigen is a second ligand for CTLA-4 and CD28[J]. Nature,1993,366:76-79.
  • 7Thomas JL, Phuong N, Robert P, et al. In vivo CD86 blockade inhibits CD4^+ T cell activation whereas CD80 blockade potentiates CD8^+ T cell activation and CTL effector function [J]. J Immunol, 2002,168:3786-3792.
  • 8David M, Claire N, Yong Z. What′s the difference between CD80 and CD86[J]. Trends Immunol, 2003,24(6):313-318.
  • 9Martin-Fontecha A, Cavallo F, Bellone M, et al. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic antitumor immunity against different mouse tumors[J].Eur J Immunol, 1996,26(8): 1851-1859.
  • 10Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenges in vitro inhibits Th1 cytokines but spares Th2[J]. J Exp Med, 1995,181(5):1869-1874.

同被引文献13

  • 1陶然,石云杰,孙中文,马泓冰,徐颖,程钢,孙玮丽,周立峰,邱玉华,张学光.鼠抗人B7-2单克隆抗体的研制及生物学特性研究[J].现代免疫学,2006,26(3):203-207. 被引量:9
  • 2Sharpe AH,Freeman GJ.The B7-CD28 superfamily[J].Nat Rev Immunol,2002,2(2):116-126.
  • 3Orabona C,Grohmann U,Belladonna ML,et al.CD28 induces immunostimulatory signals in dentritic cells via CD80 and CD86[J].Nat Immunol,2004,5 (11):1134-1142.
  • 4Kurlber G,Chopra K,Kulkarni SK,et al.Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway[J].Clin Exp Immunol,2007,147(1):155-163.
  • 5Kurlberg G,Haglind E,Scttn K,et al.Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs[J].Scand J Immunol,2000,51(3):224-230.
  • 6Mcadam AJ,Leach DR,Tada Y,et al.Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differention of CD4+ T cell[J].J Immunol,2000,165(6):5035-5040.
  • 7Anthony J,Coyle JC,Gutierrez R.The expanding B7 superfamily:increasing complexity in costimulatory signals regulating T cell function[J].Nat Immunol,2001,2(3):203-209.
  • 8Wong CK,Lit LCW,Tam LS,et al.Aberrant production of soluble costimulatory molecules CTLA-4,CD28,CD80 and CD86 in patients with systemic lupus erythematosus[J].Rheumatology,2005,44(10):989-994.
  • 9Fife BT,Griffin MD,Abbas AK,et al.Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist[J].J Clin Invest,2006,116(8):2280-2283.
  • 10Tsutsumi Y,Jie X,Ihara K,et al.Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes[J].Diabet Med,2006,23(10):1145-1150.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部